» Articles » PMID: 33217867

Bioinformatics Analysis of Multi-omics Data Identifying Molecular Biomarker Candidates and Epigenetically Regulatory Targets Associated with Retinoblastoma

Overview
Specialty General Medicine
Date 2020 Nov 21
PMID 33217867
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Retinoblastoma (RB) is the commonest malignant tumor of the infant retina. Besides genetic changes, epigenetic events are also considered to implicate the occurrence of RB. This study aimed to identify significantly altered protein-coding genes, DNA methylation, microRNAs (miRNAs), long noncoding RNAs (lncRNAs), and their molecular functions and pathways associated with RB, and investigate the epigenetically regulatory mechanism of DNA methylation modification and non-coding RNAs on key genes of RB via bioinformatics method.We obtained multi-omics data on protein-coding genes, DNA methylation, miRNAs, and lncRNAs from the Gene Expression Omnibus database. We identified differentially expressed genes (DEGs) using the Limma package in R, discerned their biological functions and pathways using enrichment analysis, and conducted the modular analysis based on protein-protein interaction network to identify hub genes of RB. Survival analyses based on The Cancer Genome Atlas clinical database were performed to analyze prognostic values of key genes of RB. Subsequently, we identified the differentially methylated genes, differentially expressed miRNAs (DEMs) and lncRNAs (DELs), and intersected them with key genes to analyze possible targets of the underlying epigenetic regulatory mechanisms. Finally, the ceRNA network of lncRNAs-miRNAs-mRNAs was constructed using Cytoscape.A total of 193 DEGs, 74 differentially methylated-DEGs (DM-DEGs), 45 DEMs, 5 DELs were identified. The molecular pathways of DEGs were enriched in cell cycle, p53 signaling pathway, and DNA replication. A total of 10 key genes were identified and found significantly associated with poor survival outcome based on survival analyses, including CDK1, BUB1, CCNB2, TOP2A, CCNB1, RRM2, KIF11, KIF20A, NDC80, and TTK. We further found that hub genes MCM6 and KIF14 were differentially methylated, key gene RRM2 was targeted by DEMs, and key genes TTK, RRM2, and CDK1 were indirectly regulated by DELs. Additionally, the ceRNA network with 222 regulatory associations was constructed to visualize the correlations between lncRNAs-miRNAs-mRNAs.This study presents an integrated bioinformatics analysis of genetic and epigenetic changes that may be associated with the development of RB. Findings may yield many new insights into the molecular biomarker candidates and epigenetically regulatory targets of RB.

Citing Articles

Molecular Biological Research on the Pathogenic Mechanism of Retinoblastoma.

Ma X, Li X, Sun Q, Luan F, Feng J Curr Issues Mol Biol. 2024; 46(6):5307-5321.

PMID: 38920989 PMC: 11202574. DOI: 10.3390/cimb46060317.


Heterogeneous Expression Patterns of the Minichromosome Maintenance Complex Members in Retinoblastoma Unveil Its Clinical Significance.

Tang J, Liu Y, Zhang Z, Ren Y, Ma Y, Wang Y Invest Ophthalmol Vis Sci. 2024; 65(1):31.

PMID: 38231525 PMC: 10795548. DOI: 10.1167/iovs.65.1.31.


Application of patient-derived induced pluripotent stem cells and organoids in inherited retinal diseases.

Liang Y, Sun X, Duan C, Tang S, Chen J Stem Cell Res Ther. 2023; 14(1):340.

PMID: 38012786 PMC: 10683306. DOI: 10.1186/s13287-023-03564-5.


Retinoblastoma: A review of the molecular basis of tumor development and its clinical correlation in shaping future targeted treatment strategies.

Rathore S, Verma A, Ratna R, Marwa N, Ghiya Y, Honavar S Indian J Ophthalmol. 2023; 71(7):2662-2676.

PMID: 37417104 PMC: 10491038. DOI: 10.4103/IJO.IJO_3172_22.


Risk of secondary tumours in patients with non-metastatic and metastatic human retinoblastoma.

Sadeghi R, Pirankuraim H, Javanshir S, Arabi M, Bereimipour A, Javanshir H Eye (Lond). 2022; 37(11):2327-2334.

PMID: 36528757 PMC: 10366135. DOI: 10.1038/s41433-022-02345-3.


References
1.
Fabian I, Onadim Z, Karaa E, Duncan C, Chowdhury T, Scheimberg I . The management of retinoblastoma. Oncogene. 2018; 37(12):1551-1560. DOI: 10.1038/s41388-017-0050-x. View

2.
Dimaras H, Corson T, Cobrinik D, White A, Zhao J, Munier F . Retinoblastoma. Nat Rev Dis Primers. 2016; 1:15021. PMC: 5744255. DOI: 10.1038/nrdp.2015.21. View

3.
Kling T, Caren H . Methylation Analysis Using Microarrays: Analysis and Interpretation. Methods Mol Biol. 2019; 1908:205-217. DOI: 10.1007/978-1-4939-9004-7_14. View

4.
Quinonez-Silva G, Davalos-Salas M, Recillas-Targa F, Ostrosky-Wegman P, Aranda D, Benitez-Bribiesca L . "Monoallelic germline methylation and sequence variant in the promoter of the RB1 gene: a possible constitutive epimutation in hereditary retinoblastoma". Clin Epigenetics. 2016; 8:1. PMC: 4706693. DOI: 10.1186/s13148-015-0167-0. View

5.
Leek J . svaseq: removing batch effects and other unwanted noise from sequencing data. Nucleic Acids Res. 2014; 42(21). PMC: 4245966. DOI: 10.1093/nar/gku864. View